ADR Biomedical Holdings Inc. (TYO:3750)
Japan · Delayed Price · Currency is JPY 785.00
+10.00 (1.29%)
Aug 27, 2026, 2:38 PM JST
ADR Biomedical Holdings Market Cap
ADR Biomedical Holdings has a market cap or net worth of 6.92 billion as of August 26, 2026. Its market cap has decreased by -14.27% in one year.
Market Cap
6.92B
Enterprise Value
7.10B
Revenue
101.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
785.00
ChartMarket Cap Chart
Since June 28, 2006, ADR Biomedical Holdings's market cap has decreased from 8.22B to 6.92B, a decrease of -15.81%. That is a compound annual growth rate of -0.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 6.92B | -7.74% |
| Dec 30, 2025 | 7.50B | -2.89% |
| Dec 30, 2024 | 7.72B | -24.06% |
| Dec 29, 2023 | 10.17B | -6.18% |
| Dec 30, 2022 | 10.84B | -4.64% |
| Dec 30, 2021 | 11.37B | -10.32% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| OncoTherapy Science | 8.57B |
| StemCell Institute | 7.77B |
| BrightPath Biotherapeutics | 7.36B |
| MEDINET | 7.07B |
| CellSource | 6.89B |
| Chiome Bioscience | 6.63B |
| Noile-Immune Biotech | 6.42B |
| PRISM BioLab Co.,LTD | 6.28B |